Disease Overview：Raynaud's phenomenon（RP）
Raynaud’s phenomenon is a vasospastic disorder characterized by episodic digital ischemia triggered by cold exposure or emotional stress, resulting in sequential color changes—pallor (white), cyanosis (blue), and rubor (red)—in fingers and toes. Primary Raynaud’s occurs in isolation, typically in young women, with benign progression; secondary Raynaud’s is associated with underlying connective tissue diseases such as systemic sclerosis, lupus, or mixed connective tissue disease, and carries higher risk of digital ulceration, gangrene, or pulmonary arterial hypertension. Diagnosis relies on clinical history, capillaroscopy (showing abnormal nailfold microvascular architecture), and serologic testing (e.g., ANA, anti-centromere, anti-Scl-70 antibodies) to differentiate primary from secondary forms. Management includes lifestyle modification, calcium channel blockers (e.g., nifedipine), phosphodiesterase-5 inhibitors (e.g., sildenafil), and, in refractory cases, intravenous prostacyclin analogs or surgical sympathectomy.
China offers distinct advantages for international patients seeking comprehensive care: leading rheumatology centers—such as Peking Union Medical College Hospital and Shanghai Renji Hospital—feature multidisciplinary teams with deep expertise in vasculopathies and scleroderma-related complications. Advanced diagnostic tools—including high-resolution nailfold capillaroscopy, laser Doppler imaging, and quantitative thermography—are routinely integrated into evaluation protocols. Clinical outcomes reflect robust experience: over 85% of secondary Raynaud’s patients achieve sustained reduction in attack frequency and severity within six months of protocol-driven therapy. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based standards or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless access—handling hospital referrals, coordinating specialist consultations, providing transparent, all-inclusive pricing, and delivering end-to-end support including visa assistance, accommodation, and post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Raynaud’s Phenomenon (Rheumatology Department)
Non-Surgical / Conservative / Medication Management
*Target Criteria:* Primary Raynaud’s or mild secondary Raynaud’s without digital ulceration, gangrene, or severe ischemia.
- •First-Line Pharmacotherapy (Oral):
- *Amlodipine (5 mg/day)*: ¥28–¥42/month → $4–$6
- •Second-Line Agents (for refractory cases):
- *Fluoxetine (20 mg/day)*: ¥75–¥110/month → $11–$16
- •Adjunctive Non-Pharmacologic Care:
- •Required Baseline Exams/Labs (per initiation):
- Doppler ultrasound of upper extremity arteries: ¥260–¥380 → $37–$54
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Secondary Raynaud’s with recurrent digital ulcers, tissue necrosis, or failure of ≥3 oral agents over 6 months; confirmed distal arterial stenosis/occlusion on angiography.
- •Digital Sympathectomy (Endoscopic Thoracic or Percutaneous):
- Bilateral procedure: ¥21,000–¥32,000 → $2,970–$4,530
- •Preoperative Workup (mandatory):
- Cardiopulmonary evaluation (ECG, PFTs, echocardiogram): ¥850–¥1,200 → $120–$170
- •Botulinum Toxin A Injection (digital blocks, per session):
Special / Complex Condition Management
- •Critical Ischemia with Early Gangrene:
- •Systemic Sclerosis–Associated Severe Raynaud’s:
Quick Selection Guide
- •Young Adult (<40), Primary Raynaud’s, Low Budget: Start with nifedipine + lifestyle modification ($6–$9/month). Avoid procedures.
- •Middle-Aged (40–65), Secondary Raynaud’s, Moderate Severity & Comorbidities (e.g., hypertension): Amlodipine + capillaroscopy-guided monitoring ($4–$6/month + $45–$68 baseline labs).
- •Elderly (>65), Digital Ulcers, Limited Mobility: Botulinum toxin injection ($400–$595/session) — lower risk than surgery, faster ulcer healing.
- •Refractory Scleroderma, Progressive Necrosis: IV iloprost or rituximab ($2,210–$5,170/course) — requires rheumatology–vascular medicine co-management.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Raynaud's phenomenon Medical Vacation Packages
Curated transparent all-inclusive packages combining Raynaud's phenomenon treatment with China top medical destinations:
